by Carlton Brown | Apr 8, 2024 |
Dr. Helen Petousis-Harris’s University of Auckland Statement of Engagement:
https://profiles.auckland.ac.nz/h-petousis-harris/professional. Accordingly, Dr. Petousis-Harris was Chairwoman of The World Health Organization Global Advisory Committee on Vaccine Safety, 5 Jun 2019 – 31 Jul 2021. This screenshot is posted here for saving to the Web Archive because i could not save it directly to the Web Archive.
by Carlton Brown | Jan 17, 2024 |
On 10th January 2024, the Drug Safety Journal Editor-in-Chief was requested to retract the following New Zealand Ministry of Health (MOH) publication by MOH employees and the Chair of Biostatistics at the University of Auckland (Springer Nature, the official journal of the International Society of Pharmacovigilance). On 16 January 2024, Ministers were informed of their predecessors’ actions and the Journal retraction request.
MOH Published study: Walton M, Pletzer V, Teunissen T, Lumley T, Hanlon T. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. Drug Saf. 2023;46(9):867-879. doi:10.1007/s40264-023-01332-1.
My Peer Review Conclusion: The published study conclusion that provided “reassurances around the safety of the vaccine” is not merited by the data when this is compared with the earlier preprint version (“preprint study” PDF) and the officially disclosed Te Whatu Ora data released in February 2023 for the same study population using a 365-day risk period. Compared with the preprint and 365-day risk period data, the published study biasedly concealed a statistically significant number of Comirnaty-related hospitalizing adverse events of special interest (AESI) and at least three AESI risk factors for ill-justified reasons. This published study does not represent reality.
A Detailed Scientific Critique can be downloaded: https://web.archive.org/web/20240109172641/https://grandsolarminimum.com/wp-content/uploads/2024/01/Drug-Safety-Journal-Retraction-Request_Ministry-of-Health_Comirnaty-Safety-Study.pdf
Emails are provided in reverse chronological order.
Begin forwarded message:
From: carlton@grandsolarminimum.com
Subject: Ministry of Health Comirnaty Safety Publication: Request for Retraction Notification (Scientific Fraud Evident): doi:10.1007/s40264-023-01332-1
Date: January 16, 2024 at 1:44:39 PM GMT+13
To: nitin.joshi@springer.com
Cc: S.Reti@ministers.govt.nz
Dear Dr. Joshi
Thank you for your email. I have copied the Minister of Health for important reasons detailed below.
I consent to you sharing my detailed scientific critique (PDF) of the Ministry of Health’s (MOH) August 2023 Comirnaty safety publication with its MOH authors (Retraction Request).
I request you also send this detailed critique (PDF) to your Journal Editor so (s)he may re-examine this study’s publication worthiness (i.e., putative Scientific Fraud).
The accompanying Officially disclosed MOH data renders the study’s conclusions false and collectively may be evidential in relation to the Crimes Act 1961.
This published study may also have supported Comirnaty’s full approval under Section 20 of the Medicines Act in November 2023, which is relevant to the Minister of Health.
Officially disclosed February 2021-2022 data shows 24,506 hospitalizing adverse events of special interest (AESI) associated with Comirnaty were whittled to 6,083 (preprint), and finally, 3,921 and at least three risk factors vanished by publication using ill-justified reasons and biased methods. The MOH data reveals an estimated-prorated 88,000 Comirnaty-related AESI and at least 3.8x more hospitalizing AESI per 100,000 (February 2021–2022) than all COVID-19 hospitalizations in 2022.
This officially disclosed MOH AESI data did not support Comirnaty’s full approval during the Government’s transition.
MOH Published study: Walton M, Pletzer V, Teunissen T, Lumley T, Hanlon T. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. Drug Saf. 2023;46(9):867-879. doi:10.1007/s40264-023-01332-1.
Detailed Critique: https://web.archive.org/web/20240109172641/https://grandsolarminimum.com/wp-content/uploads/2024/01/Drug-Safety-Journal-Retraction-Request_Ministry-of-Health_Comirnaty-Safety-Study.pdf
Thank you for promptly responding.
Dr. Carlton Brown BVSc (1986, Massey University), MBA (1997, London Business School).
Former founding CEO and co-innovator at Immune Targeting Systems Ltd (UK), “Vaccines for Mutating Viruses.”
https://independent.academia.edu/grandsolarminimum, https://grandsolarminimum.com/articles-emails-activism/, https://www.linkedin.com/in/carlton-brown-13b66232/,
https://orcid.org/0000-0003-4871-7521
On Jan 15, 2024, at 11:03 AM, Nitin Joshi <nitin.joshi@springer.com> wrote:
Dear Dr Brown
Thank you for your email.
I am writing to seek your permission to share your detailed critique (PDF) with the authors for their comments.
Best wishes
Nitin
Nitin Joshi
(he/him/his)
Editor-in-Chief, Drug Safety
Adis Publications
Springer Nature
Level 2, Aon House, Smales Farm, 74 Taharoto Rd, Takapuna, Auckland 0622, NZ
T +64(0)9 477-0749
nitin.joshi@springer.com
springernature.com
Springer Nature advances discovery by publishing robust and insightful research, supporting the development of new areas of knowledge and making ideas and information accessible around the world. We provide the best possible service to the whole research community.
From: carlton@grandsolarminimum.com <carlton@grandsolarminimum.com>
Sent: Thursday, January 11, 2024 7:44 AM
To: Nitin Joshi <nitin.joshi@springer.com>
Cc: COVID19VaccineSafetyNZ <covid19vaccinesafetynz@proton.me>; Thangeswari Rajendran <Thangeswari.Rajendran@springer.com>
Subject: Re: Request for Retraction (Drug Safety journal): Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand (based on this peer review)
Dear Dr. Nitin Joshi, Editorial Board, and Drug Safety Journal Editor
Dear Dr. Nitin Joshi, Editorial Board, and Drug Safety Journal Editor
Thank you for your email.
You already received my letter to the editor highlighting a detailed critique (PDF). Please forward that to your editor. The critique starts at line 98 / page 4 of the re-attached. The content pre-line 98 provides the broader Ministry of Health context into which your journal assists (https://web.archive.org/web/20240109172641/https://grandsolarminimum.com/wp-content/uploads/2024/01/Drug-Safety-Journal-Retraction-Request_Ministry-of-Health_Comirnaty-Safety-Study.pdf)
My email was directed at your journal editor, the peer reviewers, and the International Society of Pharmacovigilance for setting standards that permitted this study and its false conclusion to be published. That has nothing to do with the study authors now. I note your attempt to absolve the journal of responsibility for differences between preprint and published versions. You are now informed.
Your journal is being asked to do its job properly and eliminate study bias so the conclusions fit reality rather than helping the Ministry of Health conceal its iatrogenic harm and homicide committed after the MAAC overruled Medsafe to provisionally approve Comirnaty without a positive benefit-risk balance. To help you reassess the study conclusions, I have provided you the preprint and two officially disclosed Ministry of Health and Te Whatu Ora datasets, one directly associated with this published study and one complementary to it, that have been in the public domain since February 2023. You are now informed.
You will find a reference to “avoiding the detection” in relation to Section 168 of the Crimes Act 1961(https://www.legislation.govt.nz/act/public/1961/0043/latest/096be8ed81d369a9.pdf). All of those people entering the hospital as Comirnaty AESI who left via the morgue, and the 42% of acute kidney injuries whose lifespans were shortened by Comirnaty and excluded from the study at day zero of vaccination, and whose risk factor was vanished by bias could become culpable homicides, manslaughter or murder, or grievous bodily harm victims because the detection of harm was avoided.
Your journal permitted New Zealand’s Ministry of Health to take a list of 39 AESI and whittle that down to 12, seven of which accounted for a paltry 1.6% of background AESI, without disclosing its double standard methodology. At least 24,506 AESI were whittled to 6,083, and finally, 3,921 and at least three risk factors vanished using ill-justified reasons. In assessing adverse events, these authors failed to respect coronavirus vaccine mechanisms of pathogenicity and instead relied largely on a list of AESI generated by the SPEAC/Brighton Collaboration, which was funded by CEPI-affiliated scientists and largely determined before vaccine roll-out (described in V2.0 and V1.2 methodologies).
COVID-19 vaccines exacerbate preexisting disease in vital organs resulting from endothelial damage, thrombosis and embolism, and tissue-specific diseases and inflammation affecting the vascular, heart, respiratory, nervous, kidney, gastrointestinal, endocrine, and immuno-inflammatory systems beyond the narrow list of AESI diagnostic codes the authors whittled away. Freely circulating spike proteins bind the same cell entry receptors used by Ebola, Marburg, HIV, Dengue, West Nile, Zika, Venezuelan, and Eastern Equine Encephalitis, Measles, Hepatitis-B and -C, Mouse Hepatitis, Coxsackie, and SARS-CoV-1 giving it receptor-mediated entry into/interaction with all vital organs. Widespread mRNA spike protein manufacture and its persistence further add to this vital organ disease. Thus, eliminating preexisting AESI removed a very important means by which Comirnaty causes adverse events (i.e., “not of special interest”).
Comirnaty vaccination rendered New Zealanders susceptible to Antibody-Dependent Enhancement of infection. The CEPI-affiliated scientists operating under the Brighton Collaboration aegis concealed ADE within their Vaccine-Associated Enhanced Disease case definition (i.e., pathogenicity mechanism 3, Munoz et al.), which Medsafe’s Risk Management Plan specified would not be mitigated. Thus, the editor and peer reviewers failed to pick up on the February 2021 to February 2022 study period, which eliminated the possibility of assessing ADE/VAED once national borders reopened three weeks later.
Mediation/causal analysis of the Ministry of Health’s 2021-2022 national-level data shows COVID-19 vaccine doses caused excess deaths indirectly mediated by COVID-19 infection with a 6-month delay and directly with a nine and 10-month delay (i.e., comorbidity exacerbation, adverse events, AESI). This suggests a 20-day risk period is wholly inadequate for assessing Comirnaty risk. Furthermore, the one, two, and three-dose COVID-19 rates were significantly higher than the unvaccinated rates (2022). The Ministry of Health was informed it had concealed these higher rates with statistical bias by offering HSU2020 as a population total rather than HSU2021/NZStats2021 (Evidentiary Document sent to Prime Minister Ardern, 05 December 2022).
Thus, the International Society of Pharmacovigilance’s Drug Safety Journal permitted the publication of a national-level safety study that concealed harm and risk factors and failed to ensure important AESIs were assessed or specifically ring-fenced outside the study conclusion. This publication is a scientific fraud and provides no reassurance about Comirnaty’s safety.
This issue will be exposed, so make a decision if you wish the International Society of Pharmacovigilance and Nature brands to be tarnished by this issue.
Yours sincerely
Dr. Carlton Brown BVSc (1986, Massey University), MBA (1997, London Business School).
Former CEO and co-innovator at Immune Targeting Systems Ltd (UK), “Vaccines for Mutating Viruses.”
On Jan 10, 2024, at 10:21 AM, Nitin Joshi <nitin.joshi@springer.com> wrote:
Dear Dr Carlton Brown
Thank you for your email. Preprints, being preliminary versions of research papers, lack formal peer review. Consequently, there is a potential disparity between preprints and the final peer-reviewed versions published in scientific journals.
I would like to invite you to write a formal letter to the editor highlighting your concerns. We will give authors the option to reply to the letter. Both letter and the reply will then be published together in the same issue of the journal.
Best wishes
Nitin
Nitin Joshi
(he/him/his)
Editor-in-Chief, Drug Safety
Adis Publication
Springer Nature
Level 2, Aon House, Smales Farm, 74 Taharoto Rd, Takapuna, Auckland 0622, NZ
T +64(0)9 477-0749
nitin.joshi@springer.com
springernature.com
Springer Nature advances discovery by publishing robust and insightful research, supporting the development of new areas of knowledge and making ideas and information accessible around the world. We provide the best possible service to the whole research community.
From: carlton@grandsolarminimum.com <carlton@grandsolarminimum.com>
Sent: Wednesday, January 10, 2024 6:21 AM
To: Nitin Joshi <nitin.joshi@springer.com>; Thangeswari Rajendran <Thangeswari.Rajendran@springer.com>
Cc: COVID19VaccineSafetyNZ <covid19vaccinesafetynz@proton.me>
Subject: Request for Retraction (Drug Safety journal): Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand (based on this peer review)
Importance: High
Dear Drs. Nitin Joshi, Thangeswari Rajendran, and Editorial Board
Based on the following peer review, I request the International Society of Pharmacovigilance retract the New Zealand Ministry of Health’s (MOH) Comirnaty safety study from its journal (“published study”).
Published study: Walton M, Pletzer V, Teunissen T, Lumley T, Hanlon T. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. Drug Saf. 2023;46(9):867-879. doi:10.1007/s40264-023-01332-1.
Please find my peer review of this published study attached.
The published study conclusion that provided “reassurances around the safety of the vaccine” is not merited by the data when this is compared with the earlier preprint version (“preprint study”) and the officially disclosed Te Whatu Ora data released in February 2023 for the same study population using a 365-day risk period. Compared with the preprint and 365-day risk period data, the published study biasedly concealed a statistically significant number of Comirnaty-related hospitalizing adverse events of special interest (AESI) and at least three AESI risk factors for ill-justified reasons. This published study does not represent reality.
This request and peer review were saved to the Web Archive and will be sent to various Government Ministers and others because of its national importance. Thank you sincerely for publishing this evidence, which I have saved to the Web Archive.[I]
Please withdraw this misleading publication. Thank you.
Yours sincerely
Dr. Carlton Brown BVSc (1986, Massey University), MBA (1997, London Business School).
Former CEO and co-innovator at Immune Targeting Systems Ltd (UK), “Vaccines for Mutating Viruses.”
PEER REVIEW SUMMARY: The preprint study (day 0-21 risk period, 6,083 AESI) contained 1.6x more AESI than the published study (day 1-21 risk period, 3,921 AESI). Removing day zero from the risk period after the first and second doses was the key version difference, with 1,967 of this difference accounted for by acute kidney injury arising within 24 hours of vaccination. This seemingly small and ill-justified change actually eliminated acute kidney injury (AKI), venous thromboembolism, and thrombocytopenia as statistically significant risk factors. The published and preprint versions of the study also underreported the total AESI events among a list of 12 AESI categories by an average of 6.2x and 4.0x, respectively, compared with a longer 365-day risk period for the same study participants (24,506 AESI, officially disclosed data).
This study was designed with statistical expertise, which concealed hospitalizing AESI cases and risk factors. A biased list of 12 AESI categories out of a potential 39 accounted for 27.7% of the 2019 SAFE Project background AESI. Seven of these AESI categories accounted for a paltry 1.6% of the 2019 background AESI for New Zealand. The published study excluded those AESI cases who had died and failed to generate hospital discharge information. The 20-day risk period was not empirically defined and was poorly justified. Removing day zero from the post-vaccination risk period was ill-justified, yet it eliminated 42% of all AKI hospitalizations within the first 24 hours following vaccination. Such a large number of acute kidney injuries were not preexisting medical conditions.
NEW ZEALAND GOVERNMENT OFFICIALLY RELEASED DATA: This peer-review of the MOH published study utilized the following publications and data officially disclosed by the government.
1) MOH publication: Walton M, Pletzer V, Teunissen T, Lumley T, Hanlon T. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. Drug Saf. 2023;46(9):867-879. doi:10.1007/s40264-023-01332-1,
2) MOH preprint version: a PDF copy of the preprint study (03 February 2023) can be downloaded from the Web Archive.https://web.archive.org/web/20230709023307/https://grandsolarminimum.com/wp-content/uploads/2023/07/SSRN-id4329970.pdf,
3) Social Science Research Network removal of the preprint (June 2023): “Walton, Muireann and Pletzer, Vadim and Teunissen, Thomas and Lumley, Thomas and Hanlon, Timothy, Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand.https://web.archive.org/web/20230213202331/https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4329970,
4) Te Whatu Ora officially disclosed AESI data: The number of hospital admissions for each AESI following the second dose of BNT162b2 (Comirnaty) in a period of one year between 19 Feb 2021 and 19 Feb 2022 (365-day risk period, n = 24,506), and the 2021 number of public hospital admission for the same diagnostic codes irrespective of their vaccination status (n = 75,249) https://web.archive.org/web/20230324210947/https://fyi.org.nz/request/21710/response/83023/attach/4/HNZ00011430%20OIA%20Reponse.pdf
5) Statistics New Zealand 2021 population data: https://infoshare.stats.govt.nz
6) Global Vaccine Data Network dashboard: 2014-2019 SAFE Project background AESI case data, https://www.globalvaccinedatanetwork.org/ourwork/safe-project-background-rates-adverse-events-special-interest-aesis-covid-19-vaccination,
7) MOH data: https://web.archive.org/web/20220213230159/https://www.health.govt.nz/covid-19-novel-coronavirus/covid-19-data-and-statistics/covid-19-case-demographics,https://web.archive.org/web/20221231045006/https://www.health.govt.nz/covid-19-novel-coronavirus/covid-19-data-and-statistics/covid-19-case-demographics (COVID-19 hospitalizations).
CONFLICT OF INTEREST: The four Ministry of Health (MOH) employees and the Chair of Biostatistics at the University of Auckland, as study authors declared they “have no conflicts of interest to disclose” despite four being employed by the MOH in a study funded by the MOH (i.e., the National Immunization Programme budget from the MOH) using highly selected data provided by the MOH. The MOH’s Vaccine Safety Surveillance and Research Group undertook the study work, and the project was advised and critically reviewed by the National Immunization Programme, the Clinical Risk Management branch within Medsafe, and the COVID-19 Vaccine Independent Safety Monitoring Board. The New Zealand government funds university professors, and those in key positions do not get there by chance. The fact this MOH study’s conclusions were enabled by MOH employees and statistical expertise paid for by the Government means one is justified to question the authors’ conflict of interest disclosures.
STRATEGIC CONTEXT TO AESI CONCEALMENT: In New Zealand, we faced a situation where Medsafe declined to approve Comirnaty on 28 January 2021 (Officially disclosed), “Due to the unresolved concerns and additional quality, safety and efficacy data to be provided at the time of completion of the evaluation, Medsafe is unable to recommend that this product be granted consent” (Document 7)[i] Furthermore, according to the Medsafe Risk Management Plan conclusion for Comirnaty in January 2021 (Document 17), “It is considered that the safety specification for this product is currently inadequate and does not accurately reflect the important known risks, important potential risks or missing information.”[ii]
Medsafe’s 28 January 2021 decision was then overruled by the Minister of Health’s anonymous Medicines Assessment Advisory Committee (MAAC) on 03 February 2021.[iii]Medsafe had requested the MAAC focus on whether the “benefit-risk balance of Comirnaty vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, in individuals 16 years of age and older is positive” (Documents 7 and 13).[iv] The MAAC approval-overrule arose despite Medsafe stating five days previously, “The benefit-risk balance of Comirnaty (COVID-19 mRNA Vaccine) for active immunization to prevent coronavirus disease 2019 (COVID-19) …, is not clear.”[v]
An independent peer-reviewed risk-to-benefit analysis of Comirnaty’s interim Phase III clinical study safety data demonstrated there was an excess risk of serious AESI, which exceeded by4.4x the risk reduction for COVID-19 hospitalization relative to placebo (Fraiman et al., cited in the review). This risk-to-benefit analysis predicted the Ministry of Health’s 365-day risk period AESI data associated with your Journal’s published study. This data yielded 1.1x (12 AESI categories) and 3.8x (prorated, 39 AESI categories) more Comirnaty hospitalizing AESI per 100,000 (19 February 2021 to 2022) than all COVID-19 hospitalizations per 100,000 in 2022 (i.e., 11 February to 25 December 2022). Thus, the use of statistical bias that conceals AESI and risk factors in the face of a negative benefit-to-risk balance in 2020 and associated with this published Drug Safety study, plus the MAAC’s overrule of Medsafe to approve Comirnaty without a positive benefit-risk balance, intensifies the conveyance of an intent to harm while avoiding detection.
[i] Officially released by the New Zealand Government, Document 7, compiled PDF page 76,https://web.archive.org/web/20230703224316/https://www.health.govt.nz/system/files/documents/information-release/h202106950_-_response.pdf
[ii] Officially released by the New Zealand Government, Document 17, compiled PDF page 161,https://web.archive.org/web/20230703224316/https://www.health.govt.nz/system/files/documents/information-release/h202106950_-_response.pdf
[iii] Officially released by the New Zealand Government, Document 15, pg.121, MOH memo from MAAC to Medsafe (Chris James). From MAAC minutes & recommendations from 109th meeting on 2/2/21, Action and Decisions.https://web.archive.org/web/20230703224316/https://www.health.govt.nz/system/files/documents/information-release/h202106950_-_response.pdf
[iv] Officially released by the New Zealand Government, Document 7, pg.76. Document 13, pg.116, Medsafe’s Evaluation – Quality, January 2021, https://web.archive.org/web/20230703224316/https://www.health.govt.nz/system/files/documents/information-release/h202106950_-_response.pdf
[v] Officially released by the New Zealand Government, Document 10, January 2021, Clinical Evaluation, pg.86,https://web.archive.org/web/20230703224316/https://www.health.govt.nz/system/files/documents/information-release/h202106950_-_response.pdf
by Carlton Brown | Jan 9, 2024 |
Journal of Drug Safety Retraction Request and Peer Review of the New Zealand Ministry of Health’s Affiliated Study (PDF hyperlink): Walton M, Pletzer V, Teunissen T, Lumley T, Hanlon T. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. Drug Saf. 2023;46(9):867-879. doi:10.1007/s40264-023-01332-1 (Click https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442303/)
Drug Safety: The Official Journal of the International Society of Pharmacovigilance [ISoP] https://link.springer.com/journal/40264/editors
Dear Drs. Nitin Joshi, Thangeswari Rajendran, and Editorial Board (Drug Safety)
Based on the following peer review (Drug Safety Journal Retraction Request_Ministry-of-Health_Comirnaty Safety Study), I request the International Society of Pharmacovigilance retract the New Zealand Ministry of Health’s (MOH) Comirnaty safety study from its journal (“published study”).
Published study: Walton M, Pletzer V, Teunissen T, Lumley T, Hanlon T. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. Drug Saf. 2023;46(9):867-879. doi:10.1007/s40264-023-01332-1.
The published study conclusion that provided “reassurances around the safety of the vaccine” is not merited by the data when this is compared with the earlier preprint version (“preprint study”) and the officially disclosed Te Whatu Ora data released in February 2023 for the same study population using a 365-day risk period. Compared with the preprint and 365-day risk period data, the published study biasedly concealed a statistically significant number of Comirnaty-related hospitalizing adverse events of special interest (AESI) and at least three AESI risk factors for ill-justified reasons. This published study does not represent reality.
This request and peer review were saved to the Web Archive and will be sent to various Government Ministers and others because of its national importance. Thank you sincerely for publishing this evidence, which I have saved to the Web Archive.[I]
Please withdraw this misleading publication. Thank you.
Yours sincerely
Dr. Carlton Brown BVSc (1986, Massey University), MBA (1997, London Business School).
Former CEO and co-innovator at Immune Targeting Systems Ltd (UK), “Vaccines for Mutating Viruses.”
PEER REVIEW SUMMARY: The preprint study (day 0-21 risk period, 6,083 AESI) contained 1.6x more AESI than the published study (day 1-21 risk period, 3,921 AESI). Removing day zero from the risk period after the first and second doses was the key version difference, with 1,967 of this difference accounted for by acute kidney injury arising within 24 hours of vaccination. This seemingly small and ill-justified change actually eliminated acute kidney injury (AKI), venous thromboembolism, and thrombocytopenia as statistically significant risk factors. The published and preprint versions of the study also underreported the total AESI events among a list of 12 AESI categories by an average of 6.2x and 4.0x, respectively, compared with a longer 365-day risk period for the same study participants (24,506 AESI, officially disclosed data).
This study was designed with statistical expertise, which concealed hospitalizing AESI cases and risk factors. A biased list of 12 AESI categories out of a potential 39 accounted for 27.7% of the 2019 SAFE Project background AESI. Seven of these AESI categories accounted for a paltry 1.6% of the 2019 background AESI for New Zealand. The published study excluded those AESI cases who had died and failed to generate hospital discharge information. The 20-day risk period was not empirically defined and was poorly justified. Removing day zero from the post-vaccination risk period was ill-justified, yet it eliminated 42% of all AKI hospitalizations within the first 24 hours following vaccination. Such a large number of acute kidney injuries were not preexisting medical conditions.
NEW ZEALAND GOVERNMENT OFFICIALLY RELEASED DATA: This peer-review of the MOH published study utilized the following publications and data officially disclosed by the government.
- MOH publication: Walton M, Pletzer V, Teunissen T, Lumley T, Hanlon T. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. Drug Saf. 2023;46(9):867-879. doi:10.1007/s40264-023-01332-1,
- MOH preprint version: a PDF copy of the preprint study (03 February 2023) can be downloaded from the Web Archive. https://web.archive.org/web/20230709023307/https://grandsolarminimum.com/wp-content/uploads/2023/07/SSRN-id4329970.pdf,
- Social Science Research Network removal of the preprint (June 2023): “Walton, Muireann and Pletzer, Vadim and Teunissen, Thomas and Lumley, Thomas and Hanlon, Timothy, Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. https://web.archive.org/web/20230213202331/https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4329970,
- Te Whatu Ora officially disclosed AESI data: The number of hospital admissions for each AESI following the second dose of BNT162b2 (Comirnaty) in a period of one year between 19 Feb 2021 and 19 Feb 2022 (365-day risk period, n = 24,506), and the 2021 number of public hospital admission for the same diagnostic codes irrespective of their vaccination status (n = 75,249) https://web.archive.org/web/20230324210947/https://fyi.org.nz/request/21710/response/83023/attach/4/HNZ00011430%20OIA%20Reponse.pdf,
- Statistics New Zealand 2021 population data: https://infoshare.stats.govt.nz,
- Global Vaccine Data Network dashboard: 2014-2019 SAFE Project background AESI case data, https://www.globalvaccinedatanetwork.org/ourwork/safe-project-background-rates-adverse-events-special-interest-aesis-covid-19-vaccination,
- MOH data: https://web.archive.org/web/20220213230159/https://www.health.govt.nz/covid-19-novel-coronavirus/covid-19-data-and-statistics/covid-19-case-demographics, https://web.archive.org/web/20221231045006/https://www.health.govt.nz/covid-19-novel-coronavirus/covid-19-data-and-statistics/covid-19-case-demographics (COVID-19 hospitalizations).
CONFLICT OF INTEREST: The four Ministry of Health (MOH) employees and the Chair of Biostatistics at the University of Auckland, as study authors declared they “have no conflicts of interest to disclose” despite four being employed by the MOH in a study funded by the MOH (i.e., the National Immunization Programme budget from the MOH) using highly selected data provided by the MOH. The MOH’s Vaccine Safety Surveillance and Research Group undertook the study work, and the project was advised and critically reviewed by the National Immunization Programme, the Clinical Risk Management branch within Medsafe, and the COVID-19 Vaccine Independent Safety Monitoring Board. The New Zealand government funds university professors, and those in key positions do not get there by chance. The fact this MOH study’s conclusions were enabled by MOH employees and statistical expertise paid for by the Government means one is justified to question the authors’ conflict of interest disclosures.
STRATEGIC CONTEXT TO AESI CONCEALMENT: In New Zealand, we faced a situation where Medsafe declined to approve Comirnaty on 28 January 2021 (Officially disclosed), “Due to the unresolved concerns and additional quality, safety and efficacy data to be provided at the time of completion of the evaluation, Medsafe is unable to recommend that this product be granted consent” (Document 7)[ii] Furthermore, according to the Medsafe Risk Management Plan conclusion for Comirnaty in January 2021 (Document 17), “It is considered that the safety specification for this product is currently inadequate and does not accurately reflect the important known risks, important potential risks or missing information.”[iii]
Medsafe’s 28 January 2021 decision was then overruled by the Minister of Health’s anonymous Medicines Assessment Advisory Committee (MAAC) on 03 February 2021.[iv] Medsafe had requested the MAAC focus on whether the “benefit-risk balance of Comirnaty vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, in individuals 16 years of age and older is positive” (Documents 7 and 13).[v] The MAAC approval overrule arose despite Medsafe stating five days previously, “The benefit-risk balance of Comirnaty (COVID-19 mRNA Vaccine) for active immunization to prevent coronavirus disease 2019 (COVID-19) …, is not clear.”[vi]
An independent peer-reviewed risk-to-benefit analysis of Comirnaty’s interim Phase III clinical study safety data demonstrated there was an excess risk of serious AESI, which exceeded by 4.4x the risk reduction for COVID-19 hospitalization relative to placebo (Fraiman et al., cited below). This risk-to-benefit analysis predicted the Ministry of Health’s 365-day risk period AESI data associated with your Journal’s published study. This data yielded 1.1x (12 AESI categories) and 3.8x (prorated, 39 AESI categories) more Comirnaty hospitalizing AESI per 100,000 (19 February 2021 to 2022) than all COVID-19 hospitalizations per 100,000 in 2022 (i.e., 11 February to 25 December 2022). Thus, the use of statistical bias that conceals AESI and risk factors in the face of a negative benefit-to-risk balance in 2020 and associated with this published Drug Safety study, plus the MAAC’s overrule of Medsafe to approve Comirnaty without a positive benefit-risk balance, intensifies the conveyance of an intent to harm while avoiding detection.
DOWNLOAD THE PEER REVIEW: Drug Safety Journal Retraction Request_Ministry-of-Health_Comirnaty Safety Study
Drug Safety Journal Retraction Request and Peer Review of the Ministry of Health Study (PDF hyperlink): Walton M, Pletzer V, Teunissen T, Lumley T, Hanlon T. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. Drug Saf. 2023;46(9):867-879. doi:10.1007/s40264-023-01332-1 (Click https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442303/)
[i] Walton M, Pletzer V, Teunissen T, Lumley T, Hanlon T. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. Drug Saf. 2023;46(9):867-879. doi:10.1007/s40264-023-01332-1, PubMed post: https://web.archive.org/web/20230913024319/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442303/, Publication PDF: https://web.archive.org/web/20240109000219/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442303/pdf/40264_2023_Article_1332.pdf, Supplementary data file: https://web.archive.org/web/20240109000644/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442303/bin/40264_2023_1332_MOESM1_ESM.pdf
[ii] Officially released by the New Zealand Government, Document 7, compiled PDF page 76, https://web.archive.org/web/20230703224316/https://www.health.govt.nz/system/files/documents/information-release/h202106950_-_response.pdf
[iii] Officially released by the New Zealand Government, Document 17, compiled PDF page 161, https://web.archive.org/web/20230703224316/https://www.health.govt.nz/system/files/documents/information-release/h202106950_-_response.pdf
[iv] Officially released by the New Zealand Government, Document 15, pg.121, MOH memo from MAAC to Medsafe (Chris James). From MAAC minutes & recommendations from 109th meeting on 2/2/21, Action and Decisions. https://web.archive.org/web/20230703224316/https://www.health.govt.nz/system/files/documents/information-release/h202106950_-_response.pdf
[v] Officially released by the New Zealand Government, Document 7, pg.76. Document 13, pg.116, Medsafe’s Evaluation – Quality, January 2021, https://web.archive.org/web/20230703224316/https://www.health.govt.nz/system/files/documents/information-release/h202106950_-_response.pdf
[vi] Officially released by the New Zealand Government, Document 10, January 2021, Clinical Evaluation, pg.86, https://web.archive.org/web/20230703224316/https://www.health.govt.nz/system/files/documents/information-release/h202106950_-_response.pdf
by Carlton Brown | Jul 9, 2023 |
This Ministry of Health & Te Whatu Ora authored preprint paper was removed from the SSRN website at the request of the “author, SSRN, or the rights holder” (Download a PDF copy here): SSRN-id4329970
Original link (first published 03 Feb. 2023): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4329970
Web Archive link: https://web.archive.org/web/20230213202331/https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4329970
Get the Te Whatu Ora (TWO) officially disclosed data (Hyperlink), which, when analyzed, proves the MOH/TWO study’s conclusion was erroneous. Statistical and study design biases are highly evident in this study that covered up Comirnaty’s harm and risk (hospitalizing Adverse Events of Special Interest) (HNZ00011430 OIA Reponse)
A re-analysis of this study’s data to be posted soon.
by Carlton Brown | Jan 31, 2023 |
Kia ora Hon. Dr. Verrall, Minister for COVID-19 Response and Rt. Hon. Prime Minister Hipkins (sent 31/01/2023)
I am following up on your email dated 15/12/2022 when you confirmed you were seeking advice from your officials for the evidentiary document sent to ex-PM Ardern and stated that I could expect a response, which has not been forthcoming.
While Prime Minister Ardern’s claimed resignation represents a shallow step in the right direction, Government has failed to notify unsuspecting New Zealanders of the lifelong health risks and enhanced susceptibility to SARS-CoV-2 variant infections, so they can mitigate these health risks. During this intervening period, the MOH administered approximately 70,000 COVID-19 vaccine doses, putatively resulting in a significant disbenefit over the unvaccinated (i.e., COVID-19 infections, excess deaths). Given the evidence, this would make the government knowingly complicit in the unnecessary killing and harming of New Zealanders since 05/12/2022, never mind before this date.
On 11/01/2023, Professor Blakely, the Chairman of New Zealand’s Royal Commission of Inquiry into the government’s COVID-19 response, was provided the evidentiary document and asked to investigate if a genetically modified SARS-CoV-2 bioweapon coupled with predictably unsafe COVID-19 vaccination was an intentional WHO-led global genocide strategy being implemented in New Zealand as part of this government’s COVID-19 response (https://grandsolarminimum.com/2023/01/11/new-zealand-royal-commission-of-inquiry-into-new-zealands-covid-19-response/). Significant concerns were raised with Professor Blakely about the strategic intent behind government’s COVID-19 response when viewed through the lens of predictable-preventable antibody-dependent enhancement of virus infection and antigenic imprinting, the MOH’s deceitful harm-hiding statistical biases, and the government’s multi-modal censorship of the global evidence of iatrogenic harm.
Furthermore, on 20/01/2023, NZ’s Media was requested to investigate the government’s COVID-19 response. They were asked if the government’s $55 million Public Interest Journalism Fund and the conditionality placed on recipient media firms undermined their independence and resulted in bias and censorship, among other issues. The media were requested to investigate the Department of Internal Affairs Face Book take-down portal. This portal confirms government censorship of New Zealanders under the guise of protecting them from non-government mis-/dis-information while permitting government mis-/dis-information. The media were also asked if the appointment of Caroline Flora as Chief Censor raised any alarm bells about the government’s intent to censor the harm it inflicted on New Zealanders while she was associate director general of the MOH (https://grandsolarminimum.com/2023/01/20/nz-media-requested-to-investigate-the-covid19-negative-vaccine-effectiveness-sarscov2-gain-of-function-origin-and-coverups/).
The media were appraised of the 2022 draft Coroners Amendment Bill, making it possible for the government to hide the anticipated escalation of COVID-19 vaccine-associated excess mortality via the deployment of lesser qualified coroner associates able to classify vaccine-associated deaths as due to “unascertained natural causes” from behind a desk without a pathologist’s input. The media were also asked to investigate four highly evident examples of systematic UN/WHO member state government data fraud and falsifiable interpretative deceit of clinical outcomes – giving the notion of conspiracy theory absolute validity.
In my view, the Labor government, at best (unwittingly), failed to protect the public against irreparable and 100%-predictable vaccine-induced harm and, or at worst (intentionally), participated in an act of global genocide being implemented by WHO member- high income- nations, particularly. Given that this government and its system of health, justice, police, military, and media failed to protect New Zealanders, the Wakaminenga Māori Government was requested to intervene per their responsibility under He Wakaputanga and Ture Tikanga jurisdictional law.
I re-request that the Labor government urgently take responsibility for the irreparable life-shortening harm it has inflicted on the nation and notify the public so that they can mitigate their health and (re)infection risks and pressure you to withdraw these vaccines from use, while ensuring you are democratically removed from power in 2023. In the interim, the government is requested to ensure antivirals are stockpiled and made available for those at risk against the more pathogenic SARS-CoV-2 variants coming our way.
Recipients: TO: a.verrall@ministers.govt.nz c.hipkins@ministers.govt.nz CC: j.ardern@ministers.govt.nz; a.little@ministers.govt.nz; p.henare@ministers.govt.nz; a.sio@ministers.govt.nz; c.sepuloni@ministers.govt.nz; d.oconnor@ministers.govt.nz; d.parker@ministers.govt.nz; d.clark@ministers.govt.nz; m.woods@ministers.govt.nz; g.robertson@ministers.govt.nz; j.shaw@ministers.govt.nz; j.tinetti@ministers.govt.nz; k.davis@ministers.govt.nz; k.mcanulty@ministers.govt.nz; k.allan@ministers.govt.nz; m.davidson@ministers.govt.nz; m.whaitiri@ministers.govt.nz; m.wood@ministers.govt.nz; n.mahuta@ministers.govt.nz; p.twyford@ministers.govt.nz; p.williams@ministers.govt.nz; p.radhakrishnan@ministers.govt.nz; s.nash@ministers.govt.nz; w.jackson@ministers.govt.nz; cabinetoffice@dpmc.govt.nz;
Nga mihi
Dr. Carlton Brown BVSc MBA
Sent with Proton Mail secure email.
——- Original Message ——-
On Thursday, December 15th, 2022 at 9:59 AM, A Verrall (MIN) <a.verrall@ministers.govt.nz> wrote:
Kia ora Dr Brown
On behalf of Hon Dr Ayesha Verrall, Minister for COVID-19 Response, thank you for your email on 5 December 2022. The Minister has noted your letter and has asked her officials for advice on the matters you have raised. You can expect a response from the Minister in due course.
Ngā mihi,
|
Private Secretary (COVID-19) | Office of Hon Dr Ayesha Verrall
Minister for COVID-19 Response
Minister of Research, Science and Innovation |
| Minister for Seniors
Associate Minister of Health
Private Bag 18041, Parliament Buildings, Wellington 6160, New Zealand |
From: COVID19VaccineSafetyNZ [mailto:covid19vaccinesafetynz@proton.me]
Sent: Monday, 5 December 2022 4:36 PM
To: J Ardern (MIN) <j.ardern@ministers.govt.nz>; A Little Office (MIN) <a.little@ministers.govt.nz>; P Henare (MIN) <p.henare@ministers.govt.nz>; A Verrall (MIN) <a.verrall@ministers.govt.nz>; A Sio (MIN) <A.Sio@ministers.govt.nz>
Cc: C Sepuloni (MIN) <C.Sepuloni@ministers.govt.nz>; C Hipkins (MIN) <c.hipkins@ministers.govt.nz>; D OConnor (MIN) <D.OConnor@ministers.govt.nz>; D Parker (MIN) <D.Parker@ministers.govt.nz>; D Clark (MIN) <D.Clark@ministers.govt.nz>; Megan Woods (MIN) <M.Woods@ministers.govt.nz>; G Robertson (MIN) <G.Robertson@ministers.govt.nz>; J Shaw (MIN) <J.Shaw@ministers.govt.nz>; J Tinetti (MIN) <J.Tinetti@ministers.govt.nz>; K Davis (MIN) <k.davis@ministers.govt.nz>; K McAnulty (MIN) <k.mcanulty@ministers.govt.nz>; K Allan (MIN) <k.allan@ministers.govt.nz>; M Davidson (MIN) <M.Davidson@ministers.govt.nz>; M Whaitiri (MIN) <M.Whaitiri@ministers.govt.nz>; M Wood (MIN) <M.Wood@ministers.govt.nz>; N Mahuta (MIN) <n.mahuta@ministers.govt.nz>; P Twyford (MIN) <P.Twyford@ministers.govt.nz>; P Williams (MIN) <P.Williams@ministers.govt.nz>; P Radhakrishnan (MIN) <P.Radhakrishnan@ministers.govt.nz>; S Nash (MIN) <s.nash@ministers.govt.nz>; W Jackson (MIN) <w.jackson@ministers.govt.nz>; cabinetoffice@dpmc.govt.nz; covid19vaccinesafetynz@protonmail.com
Subject: (3600-2022)Open Letter & Evidentiary Document for the Prime Minister and all Ministers: COVID-19 negative vaccine effectiveness and harm evidence in New Zealand and overseas (Results, Call to Action)
Dear Rt Hon Jacinda Ardern, Prime Minister, Hon Andrew Little, Minister of Health, Hon Dr. Ayesha Verrall, Minister of COVID-19 Response, and Hon Peeni Henare and Hon Aupito William Sio, Associate Ministers of Health
In this Open Letter and evidentiary document, I share my research results on overseas government and Ministry of Health (MoH) COVID-19 vaccine surveillance and pharmacovigilance data indicating irreparable vaccine-induced harm. Furthermore, I share important evidence that SARS-CoV-2 originated from gain-of-function research, remind you that no evidence exists for an animal-to-human origin, and highlight that its potential source lay beyond Wuhan, China. A series of requests for investigations are made below linked to this evidence, including the statisticalbiases evident in the Ministry of Health and other healthcare agencies’ calculable unvaccinated COVID-19 case rates. These biases essentially eliminated the negative vaccine effectiveness harm signal from ready public view. This evidentiary document is provided by a former European corporate venture capital-funded CEO/vaccine innovator (“Vaccines for Mutating Viruses”), veterinarian with 36 years of vaccine use experience, and a private researcher. It is supported by 525 unique data, scientific, and other citations.
According to New Zealand, England, Scotland, and Canada healthcare agencies and Global surveillance data (77 nations), these vaccines failed to prevent SARS-CoV-2 infection as initially touted. Significant negative vaccine effectiveness and vaccine failure were evident with the emergence of antigenically distinct strains (i.e., Delta, Omicron). The vaccine industry experienced antibody-dependent enhancement of virus infection (ADE) and vaccine-associated enhanced disease (VAED) with three other different coronaviruses and their spike protein vaccine prototypes in the last 30 years, giving my study results a predictable context. Furthermore, one year of US lot-numbered COVID-19 vaccine-associated deaths and hospitalizations equaled 32x (Comirnaty 15.4x) and 20x (Comirnaty 10.5x) of all US vaccine-associated deaths and hospitalizations, respectively. These adverse outcomes were highly skewed and peaked across vaccine lots and were associated with a minority of lots sent to a larger number of US States. This data highlights that there was an urgent need for investigation by the US and other regulatory and healthcare agencies before expanded population use.
A vast chasm exists between the vaccine safety and efficacy experienced in 2021-2022 and the falsifiable 95% vaccine efficacy and safety proclaimed by governments with Comirnaty’s first Emergency Use Authorization in 2020 (USA). This document reviews critical pharmacotoxicology and clinical safety package deficiencies evident in overseas regulatory reviews. This helps explain why Pfizer then struggled to cope with the sheer volume of Comirnaty adverse event reports in the first 90 days post-launch. This was uncharacteristic of a safe vaccine. Numerous vaccine-associated enhanced disease mechanisms are evident by which vaccine spike proteins can cause disease or exacerbate comorbidities common to severe COVID-19 outcomes.These mechanisms place upregulated furin and angiotensin-converting enzyme-2 receptors (ACE2) and prevalent comorbidities in tissues and organs common to all three center-stage. At the same time, SARS-CoV-2’s spike protein provides its uniquely encoded furin cleavage site for the furin to cleave its S1 and S2 sub-units and activate its ACE2-receptor-mediated infectivity and pathogenicity.
Of grave concern for global public health is a gain-of-function origin to SARS-CoV-2 is indicated by its spike protein incorporating human infectivity and pathogenicity enhancing features unprecedented in nature while synthetic biology left its fingerprints. Furthermore, there is no evidence supporting a Wuhan Huanan market zoonosis because no virus progenitor or animal host was ever identified. There are two reasons for detailing a coronavirus gain-of-function origin to SARS-CoV-2. Firstly, the negative vaccine effectiveness evident in governments’ COVID-19 surveillance data could have been enhanced by a genetically modified SARS-CoV-2. Secondly, the world will be left vulnerable to future pandemics if there was no accidental release from the Wuhan Institute of Virology. At least two other potential SARS-CoV-2 origins exist beyond Wuhan, with one of these potentially involving a WHO, Five Eyes, and NATO-spearhead member nation connected with Ukraine.
The US Department of Defense (DoD) and National Institutes of Health (NIH) funding of EcoHealth Alliance (EHA, $69 million) and its connections one-degree-removed were scrutinized because EHA’s leader led a failed attempt to cover up SARS-CoV-2’s gain-of-function origin. EHA directed research that genetically modified bat SARSr-CoVs that could not infect humans so that they could. EHA’s $14.2 million funding application to the DoD in 2018 showed its intent to insert a codon-optimized furin cleavage site (FCS) into bat SARSr-CoVs. A uniquely encoded Arginine-doublet containing FCS now sits between SARS-CoV-2’s spike protein S1 and S2 sub-units, which has no precedent in known viruses and may have infringed patents. Besides EHA’s long-standing collaborations with two coronavirus gain-of-function research epicenters in the USA and China, it had another with Metabiota. Metabiota’s Series-A lead investor was a Hunter Biden part-owned investment firm. The DoD-funded Metabiota operated in Pentagon Biolabs in Ukraine and US-funded Biolabs in Cameroon and researched corona-, monkeypox-, influenza-, and Ebola viruses. Metabiota has implemented major DoD and Homeland Security contracts across Central Africa while its surveillance role in Sierra Leone’s Ebola outbreak in 2014 created significant controversies.
You are requested to investigate: (1) this New Zealand and overseas evidence for negative vaccine effectiveness, vaccine failure, and toxic vaccine lots, (2) the statistical biases evident in the MoH and other healthcare agencies’ calculable unvaccinated COVID-19 case rates, which essentially eliminated the negative vaccine effectiveness signal, (3) the role of COVID-19 vaccination in exacerbating comorbidities most frequently associated with serious-severe COVID-19 outcomes, (4) SARS-CoV-2’s gain-of-function origin while internationally championing a punitive global ban on gain-of-function R&D, and (5) the conduct of the WHO during COVID-19 linked to seven critical points detailed in section 2.7. Would you please ensure New Zealanders are updated on their recently acquired life-long health risks and that informed consent guidelines associated with COVID-19 vaccination be urgently amended? Would government please prioritize clinical research into COVID-19 antibody-dependent enhancement of virus infection, vaccine-associated enhanced disease, and antigenic imprinting in the New Zealand population? Thank you.
Yours sincerely
Dr. Carlton Brown BVSc (1986, Massey University), MBA (1997, London Business School).
Former CEO and co-innovator at Immune Targeting Systems Ltd (UK), “Vaccines for Mutating Viruses.”
Raising awareness for antibody-dependent enhancement of virus infection (ADE), vaccine-associated enhanced disease (VAED), and antigenic imprinting.
https://www.linkedin.com/in/carlton-brown-13b66232/, https://orcid.org/0000-0003-4871-7521, https://gettr.com/user/covid19_ade_vaed.
Download the Open Letter and Evidentiary Document: https://grandsolarminimum.com/2022/12/01/covid-19-vaccine-harm-evidence/.
by Carlton Brown | Jan 20, 2023 |
Documents: (1) Evidentiary Document/Open Letter and slide deck version, (2) email sent to the Prime Minister: https://grandsolarminimum.com/2022/12/01/covid-19-vaccine-harm-evidence/. (2) email sent to the Chairman of the NZ Royal Commission of Inquiry: https://grandsolarminimum.com/2023/01/11/new-zealand-royal-commission-of-inquiry-into-new-zealands-covid-19-response/. See the NZ media email recipients below my signature and citations.
Dear New Zealand’s mainstream national and regional media
Would you please forward this Open Letter email and Evidentiary Document to your management teams? All of New Zealand’s media was notified via this common email, so you all know you have been informed and requested to investigate the possibility of Genocide in New Zealand and Overseas.
Genocide in NZ? Media request to investigate the negative vaccine effectiveness evident in New Zealand and overseas, SARS-CoV-2’s gain-of-function origin, the WHO’s conduct during COVID-19, and associated cover-ups: a potential link to Prime Minister Ardern’s “shock” resignation.
Evidence: Open Letters and Evidentiary Documents were sent to Prime Minister Ardern and Ministers, and the Chairman of the New Zealand Royal Commission of Inquiry into New Zealand’s Covid-19 response (see below and attached).
I am sharing an Open Letter and Evidentiary Document that was sent to Prime Minister Ardern, Ministers, and senior government officials on 05/12/2022. Evidence was provided of negative vaccine effectiveness (neg.VE) and vaccine failure in New Zealand and overseas, SARS-CoV-2’s unequivocal gain-of-function non-zoonosis origin, the WHO IHR2005 Article breaches and critical actions that call into question its COVID-19 response intent, and their cover-ups. Numerous requests were made for specific investigations, informing New Zealanders of their irreparable COVID-19 vaccine-induced harm and lifelong health risks while amending vaccination informed consent guidelines. Dr. Ayesha Verrall confirmed that her officials were reviewing the evidence (see below). I am a former European corporate venture capital-funded CEO/vaccine innovator (“Vaccines for Mutating Viruses,” a synthetic universal pandemic influenza-A vaccine), a veterinarian with 36 years of vaccine use experience, and a researcher and author.
Professor Tony Blakely, Chairman of the New Zealand Royal Commission of Inquiry into New Zealand’s COVID-19 response, also received these documents on 11/01/2023 with an overarching question (see below), “Was a genetically modified non-zoonosis originating SARS-CoV-2 coupled with predictably unsafe COVID-19 vaccination a deliberately intended global strategy implemented by WHO member state governments as part of their COVID-19 responses”? i.e., are we amidst a global genocide knowingly or unwittingly implemented by UN/WHO member state governments?
The NZ government’s COVID-19 response raises significant concerns about its strategic intent when viewed through the lens of a 30-year vaccine industry legacy of Antibody-Dependent Enhancement of virus infection (ADE) causing negative vaccine efficacy associated with three coronaviruses and their numerous spike protein vaccine prototypes, a 60-year legacy of Antigenic Imprinting causing vaccine failure linked to viral mutation, among other issues, and the harm-hiding statistical biases evident in the MOH and overseas healthcare agencies’ calculable COVID-19 case rates. The MOH’s removal of the 12+ year population total from its weekly data updates after 10/10/22 obstructed the discovery of the deteriorating neg.VE in Q4-2022. New Zealand also experienced some of the highest excess mortality rates in the world in 2022 (preliminary analysis: weeks 1-44[i]), which coincided with booster role out (lagged response).[ii] COVID-19 vaccines failed to protect against COVID-19 infection, as misinformed in 2021, which at least 42% of the double-plus vaccinated 12+ year New Zealanders can attest to (11/12/22). The rates of COVID-19 infection were significantly higher in the vaccinated versus the unvaccinated (neg.VE, slides 3, 7, 8, 11).
Increased death and disease morbidity in other animal species were inescapable with coronavirus spike protein vaccine-induced ADE. There are numerous pathogenicity and comorbidity-exacerbator mechanisms genetically inserted into or inherent within SARS-CoV-2, which are also encoded within Comirnaty’s mRNA. These pathogenesis mechanisms make enhanced infection, life-shortening disease, exacerbated comorbidities, and death inescapable. This might explain the 2022 Coroners Amendment Bill in its 2nd reading that will make it possible to classify COVID-19-related deaths due to “unascertained natural causes” after receipt of the COVID-19 vaccine while its phase 3 clinical study is still in progress (until Feb 2023) and be fully determined from behind a desk by a coronial associate without a pathologist’s input.[iii],[iv] Is this a government cover-up ripe for unbiased journalistic investigation?
Has the government’s $55 million Public Interest Journalism Fund and the conditionality placed on recipient media firms undermined their independence, resulted in bias and censorship, and helped government ostracize and vilify those trying to expose their iatrogenic COVID-19 vaccine harm?[v],[vi],[vii],[viii] The November 2022 FOI disclosure that the Department of Internal Affairs had access to Face Book’s takedown portal confirms the government’s intent to censor New Zealanders under the guise of protecting the public from non-government misinformation.[ix] Should the appointment of the MOH’s ex-associate director general Caroline Flora as Chief Censor raise any alarm bells about the government’s intent to censor this iatrogenic harm inflicted on New Zealanders during her MOH executive leadership tenure?
When the NZ mainstream media digests the national and international evidence of the neg.VE, the irreparable COVID-19 vaccine-induced harm and mounting excess mortality, and SARS-CoV-2’s unequivocal gain-of-function origin and the players involved, media firms will face three broad choices. Keep one’s head below the parapet, come clean and blow the story wide open or continue helping the government censor the public from its iatrogenic harm. Based on what is happening overseas, and with PM Ardern’s shock resignation, the truth will emerge sooner than you realize, and then NZ’s media and journalists will be intensely scrutinized for not holding the government accountable during their COVID-19 pandemic tyranny.
In case it is tempting to label this a conspiracy theory, understand that such a notion has validity in the face of provable government lies, mis-/dis-information, data fraud and fabrication, and bias-enabled deceit. The United Nations, via the WHO, IPCC, and member state governments, have promoted global and national strategies reliant on fabricated data produced by a few or many member states or their affiliates. You will find evidence for this with NZ and overseas governments’ COVID-19 and/or their Climate Change responses and policies, including the following:
1) numerator and denominator biases evident in healthcare agency data that eliminated the neg.VE harm evidence from ready public view (section 1.1.5, slides 8, 11),
2) use of high cycle threshold (Ct>35) real-time polymerase chain reaction (PCR) diagnostic methods in 2020/21 that generated high false-positive COVID-19 case data (i.e., bogus data), which was used to measure Comirnaty’s Phase 3 clinical efficacy end-points and enable WHO member state governments’ policies during the early stage of the pandemic (section 1.5.2),
3) falsifiable 95% vaccine efficacy and safety claims (i.e., deceit) first approved by the FDA at Emergency Use Authorization (EUA) and then rubber-stamped by WHO member state regulators (section 1.5, slides 17-18, Serious adverse events of special interest following mRNA COVID-19 vaccination at EUA[x]),
4) NASA, NOAA, and Met Office global mean surface temperature (GMST) index version differences (i.e., data fabrication) that sequentially increased the pre-1975 cooling, increased the post-1975 warming, eliminated the 1998-2012 climate hiatus, reduced the 2016 peak, and generated temperature oscillations, while the global temperature is at/near the peak of a 300+ year global warming but only visible from 1880. This serves to hide the IPCC’s highly inaccurate 21st-century GMST forecasts and falsities about our glacial cycle stage (slide 20, pre-2020 GMST fabrication[xi]).
- NASA GISS fabricated a net warming from a 130-year flatline trend at Hokitika Aerodrome weather station in 2019 (i.e., NZ’s only century-plus climate index) just-in-time for the NZ government’s predetermined National Climate Change Risk Assessment (slide 20).[xii]
All claims are detailed in the Evidentiary Document and are supported by its 525 unique data, scientific publication, and information citations, which are specifically supplemented in this email (below my signature). The framing outline to an alternative perspective on the government’s COVID-19 response and its failure to ensure the safety of New Zealanders is summarized in the email/Open Letter sent to the Chairman of the New Zealand Royal Commission of Inquiry into New Zealand’s COVID-19 response (see below).
To facilitate public transparency, media recipients of this email and Open Letter/Evidentiary Document are posted online and Web archived in a list as future evidence that your media firm was informed. Please do the right thing and let New Zealanders know about their irreversible vaccine-induced lifelong harm and bring this government to public accountability in our election year. If I can be of any help to your investigation and national/regional exposure of these issues, please let me know.
Thank you.
Kind regards
Dr. Carlton Brown BVSc (Massey University) MBA (London Business School)
Former CEO and co-innovator at Immune Targeting Systems Ltd (UK), “Vaccines for Mutating Viruses.”
Raising awareness for antibody-dependent enhancement of virus infection (ADE), vaccine-associated enhanced disease (VAED), and antigenic imprinting by COVID-19 vaccination.
https://www.linkedin.com/in/carlton-brown-13b66232/, https://orcid.org/0000-0003-4871-7521, https://independent.academia.edu/grandsolarminimum, https://twitter.com/ADE_Bioweapon.
Download the Evidentiary Document: https://grandsolarminimum.com/2022/12/01/covid-19-vaccine-harm-evidence/.
Author: Revolution: Ice Age Re-Entry https://amzn.to/2PyQsxV, Google Play http://bit.ly/2JFHz08 (free).
Email recipients: aucklandnewsroom@stuff.co.nz; barry@starmedia.kiwi; chiefreporter@nelsonmail.co.nz; contact@newsroom.co.nz; daniel.tobin@ashburtoncourier.co.nz; editor@age.co.nz; editor@capitalmag.co.nz; editor@dailynews.co.nz; editor@eastbourneherald.co.nz; editor@greystar.co.nz; editor@horomail.co.nz; editor@huttnews.co.nz; editor@kapiti-observer.co.nz; editor@kmananews.co.nz; Editor@localmatters.co.nz; editor@metros.co.nz; editor@msl.co.nz; editor@odt.co.nz;editor@scoop.co.nz; editor@sunday-news.co.nz; editor@timaruherald.co.nz; editor@times.co.nz; editor@uhleader.co.nz; editor@wainews.co.nz; editorial@gisborneherald.co.nz; editorial@westportnews.co.nz; forbes@yahoo-inc.com; fran@vervemagazine.co.nz; general@starmedia.kiwi; general@starmedia.kiwi; geoff@hellomedia.co.nz; info@accessradio.org.nz; info@pctimes.co.nz; info@plainsfm.org.nz; info@planetaudio.org.nz; info@ponsonbynews.co.nz; info@thespinoff.co.nz; kip@makelemonade.nz; lucinda@latitudemagazine.co.nz; mailbox@marlexpress.co.nz; natalie.pharm@starmedia.kiwi; natalie.pharm@starmedia.kiwi; news@bayofplentytimes.co.nz; news@chronicle.co.nz; news@dailypost.co.nz; news@devonportflagstaff.co.nz; news@digitaladvance.co.nz; news@dompost.co.nz; news@fuseworksmedia.com; news@hbtoday.co.nz; news@hos.co.nz; news@mediaworks.co.nz; news@newshub.co.nz; news@newstalkzb.co.nz; news@nznewswire.co.nz; news@oamarumail.co.nz; news@radionz.co.nz; news@regionalnews.kiwi; news@star-times.co.nz; news@stl.co.nz; news@theaucklander.co.nz; news@tvnz.co.nz; news@waikatotimes.co.nz; news@wanganuichronicle.co.nz; news@wsn.co.nz; news@wsn.co.nz; newsdesk@nzherald.co.nz; newsroom@stuff.co.nz; online-editor@nzherald.co.nz; onlinenews@tvnz.co.nz; ourauckland@aucklandcouncil.govt.nz; primenews@skytv.co.nz; rachel@onehunga.co.nz; reporters@northernadvocate.co.nz; reporters@press.co.nz; reporters@press.co.nz; reporters@theguardian.co.nz; robyn.bristow@ncnews.co.nz; shareyournews@maoritelevision.com; susan.sandys@starmedia.kiwi; Terry@localmatters.co.nz; wayne.graham@encourager.co.nz; zara@newmarket.co.nz; accessradio@clear.net.nz; aucklandmag@xtra.co.nz; boptimes@wilsonandhorton.co.nz; bfm@ihug.co.nz; canta@ucsa.canterbury.ac.nz; chaff.editor@clear.net.nz; editor@consumer.org.nz; craccum@auckland.ac.nz; critic@stonebow.otago.ac.nz; letters@dominion.co.nz; editor@freeradical.co.nz; georgefm@georgefm.co.nz; letters@gisborneherald.co.nz; hauraki.herald@icn.co.nz; hb_editor@hbtoday.co.nz; indy@iconz.co.nz; editorial@investigatemagazine.com; irn@irn.co.nz; jab@globe.net.nz; levin_chronicle@wilsonandhorton.co.nz; editor@kea.lincoln.ac.nz; editor@listener.co.nz; news@mana.co.nz; editor@msl.co.nz; editor@marlexpress.co.nz; editor@newsroom.co.nz; nexus@waikato.ac.nz; northsouth@acpnz.co.nz; northern.editor@icn.co.nz; nor-age@xtra.co.nz; editor@nznewsuk.co.nz; news@nzpa.co.nz; editor_nzww@nzww.co.nz; odt.editor@alliedpress.co.nz; editorial@press.co.nz; breakfast@radioactive.co.nz; radio.massey@b-net.co.nz; news@radionz.co.nz; rdu@rdu.org.nz; info@rhema.co.nz; ripitup@frontrow.co.nz; salient@vuw.ac.nz; editor@scoop.co.nz; gordon.bain@stl.co.nz; feedback@star-times.co.nz; editor@tearaway.xtra.co.nz; adman@hcl.co.nz; UFM@waikato.ac.nz; editor@waihekegulfnews.co.nz; info@waikatotimes.co.nz; wairoa.star@xtra.co.nz; westport.news@xtra.co.nz;
[i] https://wherearethenumbers.substack.com/p/the-devils-advocate-an-exploratory
[ii] John Gibson (2022), The Rollout of COVID-19 Booster Vaccines is Associated With Rising Excess Mortality in New Zealand, https://repec.its.waikato.ac.nz/wai/econwp/2211.pdf
[iii] https://www.parliament.nz/en/pb/bills-and-laws/bills-proposed-laws/document/BILL_125886/tab/video
[iv] https://nzdsos.com/2022/10/10/submissions-to-coroners-amendment-bill/
[v] https://mch.govt.nz/sites/default/files/projects/investing_in%20sustainable_journalism_draw_down_of_tagged_contingence.pdf
[vi] https://www.taxpayers.org.nz/poll_reveals_distrust_of_taxpayer_funded_media
[vii] https://www.kiwiblog.co.nz/2022/09/hartwich_on_the_pijf.html
[viii] https://www.newsroom.co.nz/money-for-media-a-political-risk
[ix] https://fyi.org.nz/request/21009-access-to-facebooks-takedown-portal, https://expose-news.com/2022/12/03/nz-gov-has-backdoor-access-to-censor/
[x] J. Fraiman, J. Erviti, M. Jones, … P. Doshi, et al., Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults, Vaccine, Volume 40, 2022, https://doi.org/10.1016/j.vaccine.2022.08.036.
[xi] https://grandsolarminimum.com/2020/09/22/fabricating-anthropogenic-global-warming/
[xii] https://grandsolarminimum.com/2019/11/12/jacinda-arderns-global-warming-lies/
Dear Professor Tony Blakely
In light of your chairmanship of the New Zealand Royal Commission of Inquiry into New Zealand’s Covid-19 response (inquiry), I would like to share an Open Letter, and Evidentiary Document sent to Prime Minister Ardern and Ministers five hours before this inquiry was publicly announced on 05/12/22 (see attached). Dr. Ayesha Verrall (COVID-19 minister) confirmed her officials are reviewing this evidence (see below). This evidentiary document is highly relevant to the scope of this inquiry. I am a former European corporate venture capital-funded CEO/vaccine co-innovator (“Vaccines for Mutating Viruses,” UK), a veterinarian with 36 years of vaccine use experience, and a private researcher.
The evidentiary document provides national-level evidence of negative vaccine effectiveness (neg.VE) and vaccine failure in New Zealand, England, Scotland, and Canada (Study-1: 75 million vaccinated, 108 million population), globally (Study-2: 77 nations, 2.6 billion vaccinated, 3.9 billion people), and toxic vaccine lots (Study-3: Vaccine Adverse Event Reporting System lot numbered outcomes, global implications). Statistical biases evident in the Ministry of Health (MOH) and other healthcare agencies provided or calculable unvaccinated COVID-19 case rates essentially eliminated the neg.VE signal from public view. The evidentiary document also details the molecular, scientific, and other evidence for SARS-CoV-2’s gain-of-function origin, its systematic coverup, and the players involved. The evidentiary document is supported by 525 unique data, scientific, and other citations, while the inquiry framing information described below defers to those citations.
Considering the evidence detailed in Parts 1 and 2 of the evidentiary document, an obvious question arises that is highly relevant to this inquiry. Was a genetically modified non-zoonosis originating SARS-CoV-2 coupled with predictably unsafe COVID-19 vaccination a deliberately intended global strategy implemented by WHO member state governments as part of their COVID-19 responses? The NZ government’s COVID-19 response raises significant concerns about the strategic intent behind its COVID-19 response when viewed through the lens of predictable-programmable Antibody-Dependent Enhancement of virus infection (ADE, causing neg.VE) and Antigenic Imprinting (AI, causing vaccine failure) and the statistical biases evident in the MOH’s calculable unvaccinated COVID-19 case rates that eliminated the neg.VE signal.
These predictable and immunologically programmable phenomena (ADE/AI, sections 1.1.6-8) became realizable upon (re)exposure to antigenically distinct SARS-CoV-2 strains after vaccination and once our international and internal borders were reopened or relaxed. The national border closure in 2020 kept New Zealanders immunologically naive. The Auckland border closures in August 2021, the subsequent coerced/mandated vaccination, and the government and its funded media ostracization and vilification of the unvaccinated by misinformation, then the threat of festive season vacation restrictions facilitated the MOH’s Blitzkrieg-speed high vaccination rates. This COVID-19 response occurred when neg.VE was highly evident in the UKHSA data (from Report 36) and Our World in Data (OWID). Yet, the MOH narrative and informed consent guidelines failed to emphatically warn people of these now evident enhanced infection risks.
The double-tap announcements that the government had reduced the booster interval from four to three months (02/02/22) and borders would reopen starting at the end of February 2022 (03/02/22) were ominous. This significant step in the government’s COVID-19 response meant 3,063,823 people aged ≥18yrs became eligible for a booster concomitant with misinformed hyping-up of the Omicron disease risk upon border reopening. In the context of ADE, a third dose boosted the waned 2nd dose antibody levels above the putative ADE threshold. This therapeutic vaccination enabled the government to phase healthcare system demand and postpone the emergence of neg.VE. You could compare our politician-led COVID-19 response (i.e., quarantine-ensured immunological naivety, Blitzkrieg speed vaccination, a 3rd dose just before opening the borders, withholding Ivermectin treatments, end-to-end misinformation) to laboratory scientists setting up a coronavirus challenge study, which minimized the placebo group (i.e., statistical comparator). The neg.VE became evident in NZ after borders reopened (slide 4, figure legend 2), which progressively deteriorated as the year/waves progressed (slide 8). Excess mortality rates rose sharply in March 2022 (Professor Gibson https://repec.its.waikato.ac.nz/wai/econwp/2211.pdf).
Was whole population vaccination an appropriate government COVID-19 response? During the 2020s highest COVID-19 disease morbidity and mortality rate phase of the pandemic, global data highlighted the burden of serious-severe COVID-19 disease was in the elderly with multiple comorbidities. In contrast, mortality rates in the sub-70yr demographics were broadly equivalent to influenza. In 2021-22 the UKHSA Omicron data shows the hospitalization and death prevention benefit in sub-18yr and 18-59yr demographics was negligible to minimal, without factoring in the vaccine-induced harm or the irreversibly programmed ADE/AI potential. Based on the literature evidence, the NZ government conflating Omicron’s high transmissibility with high virulence was vaccination-inducing misinformation. Allowing the development of superior natural herd immunity in low-risk demographics while protecting the elderly and at-risk populations would have avoided this predictable and irreversible ADE/AI and vaccine-induced harm.
Thus, the government’s COVID-19 response of misinforming and fearmongering whole population vaccination at Blitzkrieg speed was unnecessary, inappropriate, and predictably placed the population at high risk of irreversible harm. The government’s response failed to reflect the barrage of evidence about vaccine harm, neg.VE, and vaccine failure it received from court case expert submissions, doctor petitions, the scientific literature, and overseas government data. The government and its highly funded media censored the public from the global neg.VE/vaccine failure and vaccine-associated harm while threatening doctors with medical disbarment if they did not conform to their informed consent guidelines that failed to fully warn of the risks.
I concluded the WHO/MOH/government COVID-19 response created a 21st-century perpetual human culling biosystem, likely with an accelerating fuse. This putative culling biosystem might explain NZ’s Coroner Amendment Bill and its new death classification of “unascertained natural causes” diagnosable by non-coroners. SARS-CoV-2 will putatively continue its vaccine- and HLA system-driven evolution in wave after wave of immunologically uncontested (largely) viral attack thanks to ADE, antigenic imprinting, and SARS-CoV-2’s reversion to virulence. The evolving China white lung experience might reflect ADE/AI and Omicron’s changing tissue tropism, which putatively parallels Feline Infectious Peritonitis – where death is ultimately assured.
Will the committee investigate the government’s decision not to make Ivermectin available for COVID-19 treatment and prophylaxis? Medsafe defers to the WHO and Royal New Zealand College of General Practitioners’ recommendations not to use Ivermectin. This potentially biased-political stance comes despite the overseas and systematic review evidence highlighting its safe therapeutic benefit without the lifelong risks of enhancing COVID-19 infection risk or vaccine-associated enhanced disease risk (VAED). A potential sinister motive is evident in this WHO recommendation not to use Ivermectin outside government-controlled clinical studies when viewed through the lens of SARS-CoV-2’s gain-of-function origin. Ivermectin is a specific gain-of-function countermeasure, which binds to the genetically modified spike protein receptor binding domain to inhibit cell entry and SARS-CoV-2’s infectivity and pathogenesis (section 2.6). The WHO recommendation eliminated an important COVID-19 disease control lever for member nations, which ensured their use of predictable ADE/AI programming vaccination.
In promoting vaccination under its COVID-19 response did the NZ government’s claim that Comirnaty was 95% efficacious and safe at Emergency Use Authorization (EUA) have validity? When you review sections 1.3-5 (slides 13, 17, & 18), Comirnaty’s safety and efficacy claims were falsifiable on multiple counts in December 2020 with the FDA’s first Emergency Use Authorization (EUA). Thus, it would appear that Medsafe rubber-stamped that flawed FDA gate-opening lead. Furthermore, when discussing Comirnaty’s safety publicly, this government should have emphasized the 3-decade vaccine industry legacy of ADE with three different coronaviruses and their spike protein-based vaccine prototypes and the 6-decade legacy of antigenic imprinting. This body of vaccine science teaches us that MOH/government should have been cautious in claiming Comirnaty was safe based only on a mean of 46 days of pre-EUA monitoring and that the safety narrative should have reflected the emergence of antigenically distinct strains after vaccination (i.e., 2nd and 3rd pandemic waves). The government’s failure to emphatically warn of the ADE/AI risks was both conspicuous and ominous.
The government’s COVID-19 response failed to reflect that Comirnaty was a first-in-class gene therapy vaccine with serious unassessed potential for autoimmunity, genotoxicity, reverse transcription, and genome incorporation, cancer, prion disease, and spike protein shedding (sections 1.3-4). The government’s safety narrative also failed to reflect the lack of biomarker evidence at EUA for predictable pathogenesis mechanisms and the premature unblinding of the pivotal phase 3 study 28 months early (i.e., eliminating the statistical comparator group). As such, it was highly revealing of government intent that the National Immunization Programme website does not detail any post-marketing studies for predictable-programmable ADE, AI, and VAED (i.e., predictable pathology mechanism biomarkers). This lack of post-marketing studies for ADE/AI/VAED indicates that the government did not prioritize the NZ population’s safety in its COVID-19 response.
Under the government’s COVID-19 response was the immunological programming of neg.VE (ADE) and vaccine failure (antigenic imprinting) and the harm-hiding denominator bias intentional? One must look at both the MOH/government’s and WHO’s actions to address this question.
Based on the MOH surveillance data, its harm-hiding denominator bias before 08/08/2022, and other issues detailed above, a catastrophic public health failure or deliberate intention to irreversibly harm the population has occurred in New Zealand (and England, Scotland, Canada, and elsewhere) associated with this government’s COVID-19 response. Were the government or a powerful minority of government and its expert advisors aware of the ADE, AI, and VAED potential for Comirnaty? If not, why not? After all, Comirnaty’s potentiality for neg.VE and vaccine failure were highly evident from the literature and should have been obvious to MOH advisory experts.
Given the MOH’s well-described shortcomings for HSU2020 as a population total (i.e., it underestimated the residual unvaccinated population) and its provision before/during the Omicron brunt (HSU Population page in https://www.health.govt.nz/system/files/documents/pages/covid_vaccinations_22_03_2022.xlsx), it would appear the MOH enacted some retrospective derrière covering to justify its use of HSU2020. The MOH requested Stats NZ peer review its methods used to create the HSU population and its suitability as a denominator (referencing HSU2020) even though MOH statisticians would have known it would underestimate the unvaccinated population and increase the unvaccinated COVID-19 case rates (i.e., 1.9x over NZStats2021 and 2.6x over HSU2022). The Stats NZ post first appeared on the web archive on 04/08/2022, four days before the MOH switched to HSU2022. Raising further concerns about the government’s COVID-19 response intent is that once HSU2022 went live on 08/08/22, the neg.VE became visible for both infections and hospitalizations (slide 8). The MOH has still not notified the public about the irreparable vaccine-induced harm while promoting COVID-19 vaccination.
The intentions behind the global COVID-19 response, which New Zealand is a party to, focuses on the WHO and its influence over WHO member state governments. Any review of New Zealand’s COVID-19 response must reflect the WHO-coordinated global response and UN politics. At the global level, it is essential to reflect on SARS-CoV-2’s unequivocal gain-of-function non-zoonosis origin and the WHO’s IHR2005 Article breaches, missteps, and its critical actions that raise important questions about its pandemic conduct (section 2.5-7).
Importantly, those one degree removed from EcoHealth Alliance’s attempted gain-of-function coverup must be investigated (Part 2). This investigation should include the WHO (i.e., seven critical issues), the US Department of Defense (DoD) and its Ukraine BTRP-Biolab partners (the Russia Federation Government calls them bioweapon labs) like the WHO, World Organization for Animal Health, and CDC, and the National Institutes of Health and Hunter Biden and his ex-Metabiota (i.e., DoD funded Ukraine-Cameroon biolab operations, corona-, monkeypox-, influenza-, Ebola- virus zoonosis surveillance). Be reminded there is zero hard evidence for a zoonosis. SARS-like cases were diagnosed at the Wuhan Military World Games in October 2019, and Wuhan was locked down. SARS-CoV-2 cases were also retrospectively confirmed in Italy, Sweden, Brazil, and France in November-December 2019.
These SARS-like cases mean an unproven accidental release blamed on the Wuhan Institute of Virology is confounded. Thus, the WHO misinformed the world on the origin and timeline for the COVID-19 pandemic. What if foreign soldiers accidentally or deliberately brought the virus to the games, which got blamed on the Wuhan Institute of Virology because they had conducted gain-of-function research? Furthermore, the molecular evidence for enhanced infectivity and pathogenicity, residual synthetic biology fingerprints, and evidence of a potential Moderna patent infringement indicate the global public has been misinformed and censored from the truth, which could also implicate a non-China origin.
Worse still, under this backdrop of misinformation and censorship, the WHO member state governments promoted gene therapy vaccines, which delivered genetically modified Wuhan Hu-1 strain spike protein mRNA encoded pathogenicity mechanisms not obvious in SARS-CoV-2’s closest precursor (i.e., a Furin Cleavage Site/RBD-ACE2/furin-, CD147-, LFA-1-, autoimmunity- mediated, prion sequences, and a spike protein nuclear translocation signal). Given the attempts at global censorship by EcoHealth Alliance (i.e., affiliated with or funded by WHO, DoD, NIH, USAID, and Metabiota), the seven critical issues related to WHO conduct, and other instances of questionable WHO leadership (section 2.7) it is hard to trust the WHO’s strategic intent.
Based on the above overview and detailed analysis in the evidentiary document, I believe the world is amidst a globally coordinated genocide knowingly or unwittingly implemented by WHO member state governments. In my view, one could justifiably be suspicious of genocide with WHO member state government COVID-19 responses that embraced most of the points (a)-(h):
- Their use of high cycle threshold PCR that generated policy-enabling high false positive data (2020-21),
- Those whose drug regulator approved falsifiable COVID-19 vaccine efficacy and safety claims with critical shortcomings in the preclinical and clinical safety data packages and their study designs that avoided the detection of harm,
- Those who withheld the gain-of-function countermeasure Ivermectin from treatment and prophylaxis protocols, which ensured their use of harmful vaccination,
- Those who rapidly achieved high vaccination rates while censoring doctors who opposed their informed consent guidelines,
- Those where statistical bias was evident in provided or calculable unvaccinated COVID-19 case rates, which eliminated the neg.VE and vaccine failure from ready public view,
- Those whose pharmacovigilance and coroners largely attributed vaccine-associated/exacerbated injuries and deaths as not attributable to vaccination,
- Those who controlled and censored the media narrative with financial inducements, and
- Those governments who censored social media through backdoor channels.
This email constitutes an Open Letter and, together with the evidentiary document, represents an informal submission of inquiry evidence. Please urgently review the neg.VE and vaccine failure problem and request government address the requests made in my Open Letter to them on 05/12/2022. This open letter to you was shared within New Zealand and posted online.
Thank you.
Kind regards
Dr. Carlton Brown BVSc (Massey University) MBA (London Business School)
Former CEO and co-innovator at Immune Targeting Systems Ltd (UK), “Vaccines for Mutating Viruses.”
Raising awareness for antibody-dependent enhancement of virus infection (ADE), vaccine-associated enhanced disease (VAED), and antigenic imprinting by COVID-19 vaccination.
https://www.linkedin.com/in/carlton-brown-13b66232/, https://orcid.org/0000-0003-4871-7521, https://independent.academia.edu/grandsolarminimum, https://twitter.com/ADE_Bioweapon.
Download the Evidentiary Document: https://grandsolarminimum.com/2022/12/01/covid-19-vaccine-harm-evidence/.
Author: Revolution: Ice Age Re-Entry https://amzn.to/2PyQsxV, Google Play http://bit.ly/2JFHz08 (free).
Sent with Proton Mail secure email.
——- Forwarded Message ——-
From: A Verrall (MIN) <a.verrall@ministers.govt.nz>
Date: On Thursday, December 15th, 2022 at 9:59 AM
Subject: RE: (3600-2022)Open Letter & Evidentiary Document for the Prime Minister and all Ministers: COVID-19 negative vaccine effectiveness and harm evidence in New Zealand and overseas (Results, Call to Action)
To: COVID19VaccineSafetyNZ <covid19vaccinesafetynz@proton.me>
Kia ora Dr Brown
On behalf of Hon Dr Ayesha Verrall, Minister for COVID-19 Response, thank you for your email on 5 December 2022. The Minister has noted your letter and has asked her officials for advice on the matters you have raised. You can expect a response from the Minister in due course.
Ngā mihi,
|
Private Secretary (COVID-19) | Office of Hon Dr Ayesha Verrall
Minister for COVID-19 Response
Minister of Research, Science and Innovation |
| Minister for Seniors
Associate Minister of Health
Private Bag 18041, Parliament Buildings, Wellington 6160, New Zealand |
From: COVID19VaccineSafetyNZ [mailto:covid19vaccinesafetynz@proton.me]
Sent: Monday, 5 December 2022 4:36 PM
To: J Ardern (MIN) <j.ardern@ministers.govt.nz>; A Little Office (MIN) <a.little@ministers.govt.nz>; P Henare (MIN) <p.henare@ministers.govt.nz>; A Verrall (MIN) <a.verrall@ministers.govt.nz>; A Sio (MIN) <A.Sio@ministers.govt.nz>
Cc: C Sepuloni (MIN) <C.Sepuloni@ministers.govt.nz>; C Hipkins (MIN) <c.hipkins@ministers.govt.nz>; D OConnor (MIN) <D.OConnor@ministers.govt.nz>; D Parker (MIN) <D.Parker@ministers.govt.nz>; D Clark (MIN) <D.Clark@ministers.govt.nz>; Megan Woods (MIN) <M.Woods@ministers.govt.nz>; G Robertson (MIN) <G.Robertson@ministers.govt.nz>; J Shaw (MIN) <J.Shaw@ministers.govt.nz>; J Tinetti (MIN) <J.Tinetti@ministers.govt.nz>; K Davis (MIN) <k.davis@ministers.govt.nz>; K McAnulty (MIN) <k.mcanulty@ministers.govt.nz>; K Allan (MIN) <k.allan@ministers.govt.nz>; M Davidson (MIN) <M.Davidson@ministers.govt.nz>; M Whaitiri (MIN) <M.Whaitiri@ministers.govt.nz>; M Wood (MIN) <M.Wood@ministers.govt.nz>; N Mahuta (MIN) <n.mahuta@ministers.govt.nz>; P Twyford (MIN) <P.Twyford@ministers.govt.nz>; P Williams (MIN) <P.Williams@ministers.govt.nz>; P Radhakrishnan (MIN) <P.Radhakrishnan@ministers.govt.nz>; S Nash (MIN) <s.nash@ministers.govt.nz>; W Jackson (MIN) <w.jackson@ministers.govt.nz>; cabinetoffice@dpmc.govt.nz; covid19vaccinesafetynz@protonmail.com
Subject: (3600-2022)Open Letter & Evidentiary Document for the Prime Minister and all Ministers: COVID-19 negative vaccine effectiveness and harm evidence in New Zealand and overseas (Results, Call to Action)
Dear Rt Hon Jacinda Ardern, Prime Minister, Hon Andrew Little, Minister of Health, Hon Dr. Ayesha Verrall, Minister of COVID-19 Response, and Hon Peeni Henare and Hon Aupito William Sio, Associate Ministers of Health
In this Open Letter and evidentiary document, I share my research results on overseas government and Ministry of Health (MoH) COVID-19 vaccine surveillance and pharmacovigilance data indicating irreparable vaccine-induced harm. Furthermore, I share important evidence that SARS-CoV-2 originated from gain-of-function research, remind you that no evidence exists for an animal-to-human origin, and highlight that its potential source lay beyond Wuhan, China. A series of requests for investigations are made below linked to this evidence, including the statisticalbiases evident in the Ministry of Health and other healthcare agencies’ calculable unvaccinated COVID-19 case rates. These biases essentially eliminated the negative vaccine effectiveness harm signal from ready public view. This evidentiary document is provided by a former European corporate venture capital-funded CEO/vaccine innovator (“Vaccines for Mutating Viruses”), veterinarian with 36 years of vaccine use experience, and a private researcher. It is supported by 525 unique data, scientific, and other citations.
According to New Zealand, England, Scotland, and Canada healthcare agencies and Global surveillance data (77 nations), these vaccines failed to prevent SARS-CoV-2 infection as initially touted. Significant negative vaccine effectiveness and vaccine failure were evident with the emergence of antigenically distinct strains (i.e., Delta, Omicron). The vaccine industry experienced antibody-dependent enhancement of virus infection (ADE) and vaccine-associated enhanced disease (VAED) with three other different coronaviruses and their spike protein vaccine prototypes in the last 30 years, giving my study results a predictable context. Furthermore, one year of US lot-numbered COVID-19 vaccine-associated deaths and hospitalizations equaled 32x (Comirnaty 15.4x) and 20x (Comirnaty 10.5x) of all US vaccine-associated deaths and hospitalizations, respectively. These adverse outcomes were highly skewed and peaked across vaccine lots and were associated with a minority of lots sent to a larger number of US States. This data highlights that there was an urgent need for investigation by the US and other regulatory and healthcare agencies before expanded population use.
A vast chasm exists between the vaccine safety and efficacy experienced in 2021-2022 and the falsifiable 95% vaccine efficacy and safety proclaimed by governments with Comirnaty’s first Emergency Use Authorization in 2020 (USA). This document reviews critical pharmacotoxicology and clinical safety package deficiencies evident in overseas regulatory reviews. This helps explain why Pfizer then struggled to cope with the sheer volume of Comirnaty adverse event reports in the first 90 days post-launch. This was uncharacteristic of a safe vaccine. Numerous vaccine-associated enhanced disease mechanisms are evident by which vaccine spike proteins can cause disease or exacerbate comorbidities common to severe COVID-19 outcomes.These mechanisms place upregulated furin and angiotensin-converting enzyme-2 receptors (ACE2) and prevalent comorbidities in tissues and organs common to all three center-stage. At the same time, SARS-CoV-2’s spike protein provides its uniquely encoded furin cleavage site for the furin to cleave its S1 and S2 sub-units and activate its ACE2-receptor-mediated infectivity and pathogenicity.
Of grave concern for global public health is a gain-of-function origin to SARS-CoV-2 is indicated by its spike protein incorporating human infectivity and pathogenicity enhancing features unprecedented in nature while synthetic biology left its fingerprints. Furthermore, there is no evidence supporting a Wuhan Huanan market zoonosis because no virus progenitor or animal host was ever identified. There are two reasons for detailing a coronavirus gain-of-function origin to SARS-CoV-2. Firstly, the negative vaccine effectiveness evident in governments’ COVID-19 surveillance data could have been enhanced by a genetically modified SARS-CoV-2. Secondly, the world will be left vulnerable to future pandemics if there was no accidental release from the Wuhan Institute of Virology. At least two other potential SARS-CoV-2 origins exist beyond Wuhan, with one of these potentially involving a WHO, Five Eyes, and NATO-spearhead member nation connected with Ukraine.
The US Department of Defense (DoD) and National Institutes of Health (NIH) funding of EcoHealth Alliance (EHA, $69 million) and its connections one-degree-removed were scrutinized because EHA’s leader led a failed attempt to cover up SARS-CoV-2’s gain-of-function origin. EHA directed research that genetically modified bat SARSr-CoVs that could not infect humans so that they could. EHA’s $14.2 million funding application to the DoD in 2018 showed its intent to insert a codon-optimized furin cleavage site (FCS) into bat SARSr-CoVs. A uniquely encoded Arginine-doublet containing FCS now sits between SARS-CoV-2’s spike protein S1 and S2 sub-units, which has no precedent in known viruses and may have infringed patents. Besides EHA’s long-standing collaborations with two coronavirus gain-of-function research epicenters in the USA and China, it had another with Metabiota. Metabiota’s Series-A lead investor was a Hunter Biden part-owned investment firm. The DoD-funded Metabiota operated in Pentagon Biolabs in Ukraine and US-funded Biolabs in Cameroon and researched corona-, monkeypox-, influenza-, and Ebola viruses. Metabiota has implemented major DoD and Homeland Security contracts across Central Africa while its surveillance role in Sierra Leone’s Ebola outbreak in 2014 created significant controversies.
You are requested to investigate: (1) this New Zealand and overseas evidence for negative vaccine effectiveness, vaccine failure, and toxic vaccine lots, (2) the statistical biases evident in the MoH and other healthcare agencies’ calculable unvaccinated COVID-19 case rates, which essentially eliminated the negative vaccine effectiveness signal, (3) the role of COVID-19 vaccination in exacerbating comorbidities most frequently associated with serious-severe COVID-19 outcomes, (4) SARS-CoV-2’s gain-of-function origin while internationally championing a punitive global ban on gain-of-function R&D, and (5) the conduct of the WHO during COVID-19 linked to seven critical points detailed in section 2.7. Would you please ensure New Zealanders are updated on their recently acquired life-long health risks and that informed consent guidelines associated with COVID-19 vaccination be urgently amended? Would government please prioritize clinical research into COVID-19 antibody-dependent enhancement of virus infection, vaccine-associated enhanced disease, and antigenic imprinting in the New Zealand population? Thank you.
Yours sincerely
Dr. Carlton Brown BVSc (1986, Massey University), MBA (1997, London Business School).
Former CEO and co-innovator at Immune Targeting Systems Ltd (UK), “Vaccines for Mutating Viruses.”
Raising awareness for antibody-dependent enhancement of virus infection (ADE), vaccine-associated enhanced disease (VAED), and antigenic imprinting.
https://www.linkedin.com/in/carlton-brown-13b66232/, https://orcid.org/0000-0003-4871-7521, https://gettr.com/user/covid19_ade_vaed.
Download the Open Letter and Evidentiary Document: https://grandsolarminimum.com/2022/12/01/covid-19-vaccine-harm-evidence/.
Sent with Proton Mail secure email.
Recent Comments